AI assistant
Sending…
RESMED INC — Director's Dealing 2020
Nov 14, 2020
30071_dirs_2020-11-13_26620cff-0653-41fc-a9f4-8be5a0766b02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2020-11-05
Reporting Person: Leong Justin (President, Asia Latin America)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-05 | ReMed Common Stock | M | 7740 | $57.76 | Acquired | 33126 | Direct |
| 2020-11-05 | ReMed Common Stock | S | 7740 | $211.36 | Disposed | 25386 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-05 | ResMed Common Stock Options | $57.76 | M | 7740 | Disposed | 2023-11-16 | ResMed Common Stock (7740) | Direct |
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Regulatory Filings
2026
Jan 29